These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32719071)
1. Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression. Zhang Y; Chen C; Chen SJ; Chen XQ; Shuster DJ; Puszczalo PD; Fancher RM; Yang Z; Sinz M; Shen H J Pharmacol Exp Ther; 2020 Oct; 375(1):139-151. PubMed ID: 32719071 [TBL] [Abstract][Full Text] [Related]
2. Repression of Organic Anion Transporting Polypeptide (OATP) 1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Downregulation in Cynomolgus Monkeys Treated with Chenodeoxycholic Acid. Zhang Y; Chen SJ; Chen C; Chen XQ; Chatterjee S; Shuster DJ; Dexter H; Armstrong L; Joshi EM; Yang Z; Shen H Drug Metab Dispos; 2022 Aug; 50(8):1077-1086. PubMed ID: 35636769 [TBL] [Abstract][Full Text] [Related]
3. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans. Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847 [TBL] [Abstract][Full Text] [Related]
4. Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo. Niu C; Wang Y; Zhao X; Tep S; Murakami E; Subramanian R; Smith B; Lai Y Drug Metab Dispos; 2019 Dec; 47(12):1433-1442. PubMed ID: 31582395 [TBL] [Abstract][Full Text] [Related]
5. Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition. Gu X; Wang L; Gan J; Fancher RM; Tian Y; Hong Y; Lai Y; Sinz M; Shen H Drug Metab Dispos; 2020 Aug; 48(8):724-734. PubMed ID: 32482623 [TBL] [Abstract][Full Text] [Related]
6. Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition. Shen H; Christopher L; Lai Y; Gong J; Kandoussi H; Garonzik S; Perera V; Garimella T; Humphreys WG Drug Metab Dispos; 2018 Aug; 46(8):1075-1082. PubMed ID: 29777022 [TBL] [Abstract][Full Text] [Related]
7. Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions. Kunze A; Ediage EN; Dillen L; Monshouwer M; Snoeys J Clin Pharmacokinet; 2018 Dec; 57(12):1559-1570. PubMed ID: 29663259 [TBL] [Abstract][Full Text] [Related]
8. Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics. Robbins JA; Menzel K; Lassman M; Zhao T; Fancourt C; Chu X; Mostoller K; Witter R; Marceau West R; Stoch SA; McCrea JB; Iwamoto M Clin Pharmacol Ther; 2022 Mar; 111(3):664-675. PubMed ID: 34888851 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method. Chan GH; Houle R; Zhang J; Katwaru R; Li Y; Chu X Drug Metab Dispos; 2023 Sep; 51(9):1089-1104. PubMed ID: 37137718 [TBL] [Abstract][Full Text] [Related]
10. Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model. Bechtold BJ; Lynch KD; Oyanna VO; Call MR; Graf TN; Oberlies NH; Clarke JD Mol Pharm; 2024 May; 21(5):2284-2297. PubMed ID: 38529622 [TBL] [Abstract][Full Text] [Related]
11. Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition. Lai Y; Mandlekar S; Shen H; Holenarsipur VK; Langish R; Rajanna P; Murugesan S; Gaud N; Selvam S; Date O; Cheng Y; Shipkova P; Dai J; Humphreys WG; Marathe P J Pharmacol Exp Ther; 2016 Sep; 358(3):397-404. PubMed ID: 27317801 [TBL] [Abstract][Full Text] [Related]
12. Characterization and Prediction of Organic Anion Transporting Polypeptide 1B Activity in Prostate Cancer Patients on Abiraterone Acetate Using Endogenous Biomarker Coproporphyrin I. Wang Z; Luk KHY; Cheong EJY; Tham SM; Periaswami R; Toh PC; Wang Z; Wu QH; Tsang WC; Kesavan A; Wong ASC; Wong PT; Lim F; Chiong E; Chan ECY Drug Metab Dispos; 2024 Oct; 52(11):1356-1362. PubMed ID: 39187385 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic Determinants of Daprodustat Drug-Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B-CYP2C8 Interplay. Bi YA; Jordan S; King-Ahmad A; West MA; Varma MVS Clin Pharmacol Ther; 2024 Jun; 115(6):1336-1345. PubMed ID: 38404228 [TBL] [Abstract][Full Text] [Related]
14. Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species. Shen H; Dai J; Liu T; Cheng Y; Chen W; Freeden C; Zhang Y; Humphreys WG; Marathe P; Lai Y J Pharmacol Exp Ther; 2016 May; 357(2):382-93. PubMed ID: 26907622 [TBL] [Abstract][Full Text] [Related]
15. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. Bednarczyk D; Boiselle C Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540 [TBL] [Abstract][Full Text] [Related]
16. Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in Dogs. Liu R; Ma B; Mok MM; Murray BP; Subramanian R; Lai Y Drug Metab Dispos; 2024 Feb; 52(3):236-241. PubMed ID: 38123963 [TBL] [Abstract][Full Text] [Related]
17. Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin. Prueksaritanont T; Chu X; Evers R; Klopfer SO; Caro L; Kothare PA; Dempsey C; Rasmussen S; Houle R; Chan G; Cai X; Valesky R; Fraser IP; Stoch SA Br J Clin Pharmacol; 2014 Sep; 78(3):587-98. PubMed ID: 24617605 [TBL] [Abstract][Full Text] [Related]
18. Coproporphyrin-I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug-Drug Interactions: Cedirogant Case Study. Kikuchi R; Qian Y; Badawi M; Savaryn JP; Gannu S; Eldred A; Hao S; Salem AH; Liu W; Klein CE; Mohamed MF Clin Pharmacol Ther; 2024 Nov; 116(5):1334-1342. PubMed ID: 39102854 [TBL] [Abstract][Full Text] [Related]
19. Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel. Mori D; Ishida H; Mizuno T; Kusumoto S; Kondo Y; Izumi S; Nakata G; Nozaki Y; Maeda K; Sasaki Y; Fujita KI; Kusuhara H Drug Metab Dispos; 2020 May; 48(5):387-394. PubMed ID: 32114508 [TBL] [Abstract][Full Text] [Related]
20. Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides. Thakare R; Gao H; Kosa RE; Bi YA; Varma MVS; Cerny MA; Sharma R; Kuhn M; Huang B; Liu Y; Yu A; Walker GS; Niosi M; Tremaine L; Alnouti Y; Rodrigues AD Drug Metab Dispos; 2017 Jul; 45(7):721-733. PubMed ID: 28396527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]